We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

REGN Regeneron Pharmaceuticals Inc

7.63 (0.91%)
Last Updated: 13:56:31
Delayed by 15 minutes


Draw Mode:

Volume 301,647
Bid Price 847.54
Ask Price 848.02
News (2)
Day High 849.00


52 Week Range


Day Low 838.44
Share Name Share Symbol Market Stock Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
7.63 0.91% 847.77 13:56:31
Open Price Low Price High Price Close Price Previous Close
838.44 838.44 849.00 840.14
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
14,611 301,647 US$ 841.57 US$ 253,856,761 - 668.00 - 853.97
Last Trade Type Quantity Price Currency
13:56:30 4 US$ 847.75 USD

Regeneron Pharmaceuticals (REGN) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Regeneron Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
92.09B 108.95M - 12.26B 4.34B 39.82 21.23
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Regeneron Pharmaceuticals News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No REGN Message Board. Create One! See More Posts on REGN Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week804.55850.275802.55835.01467,48543.225.37%
1 Month795.92850.275784.9594811.85476,31651.856.51%
3 Months824.80853.97769.19815.40450,46222.972.78%
6 Months747.84853.97684.805783.99532,12699.9313.36%
1 Year730.17853.97668.00770.68563,147117.6016.11%
3 Years477.50853.97441.00642.29705,441370.2777.54%
5 Years382.17853.97271.37553.65786,760465.60121.83%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |